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Abstract
Growing experimental evidence indicates that, in addition to the physical virion components, the non-structural proteins of
hepatitis C virus (HCV) are intimately involved in orchestrating morphogenesis. Since it is dispensable for HCV RNA
replication, the non-structural viral protein NS2 is suggested to play a central role in HCV particle assembly. However,
despite genetic evidences, we have almost no understanding about NS2 protein-protein interactions and their role in the
production of infectious particles. Here, we used co-immunoprecipitation and/or fluorescence resonance energy transfer
with fluorescence lifetime imaging microscopy analyses to study the interactions between NS2 and the viroporin p7 and the
HCV glycoprotein E2. In addition, we used alanine scanning insertion mutagenesis as well as other mutations in the context
of an infectious virus to investigate the functional role of NS2 in HCV assembly. Finally, the subcellular localization of NS2
and several mutants was analyzed by confocal microscopy. Our data demonstrate molecular interactions between NS2 and
p7 and E2. Furthermore, we show that, in the context of an infectious virus, NS2 accumulates over time in endoplasmic
reticulum-derived dotted structures and colocalizes with both the envelope glycoproteins and components of the
replication complex in close proximity to the HCV core protein and lipid droplets, a location that has been shown to be
essential for virus assembly. We show that NS2 transmembrane region is crucial for both E2 interaction and subcellular
localization. Moreover, specific mutations in core, envelope proteins, p7 and NS5A reported to abolish viral assembly
changed the subcellular localization of NS2 protein. Together, these observations indicate that NS2 protein attracts the
envelope proteins at the assembly site and it crosstalks with non-structural proteins for virus assembly.
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Introduction
The hepatitis C virus (HCV) has a high propensity to establish a
persistent infection in the human liver. Approximately 170 million
people suffer from chronic hepatitis C and are at risk to develop
cirrhosis and hepatocellular carcinoma [1]. Current antiviral
therapy is based on the use of polyethylene glycol conjugated
interferon alpha in combination with ribavirin. However, this
treatment is expensive, relatively toxic and effective in only
approximately half of the treated patients [2]. A better
understanding of the HCV life cycle is therefore essential for the
development of more efficacious and better tolerated anti-HCV
treatments.
HCV is an enveloped virus that belongs to the Hepacivirus genus
in the Flaviviridae family [3]. HCV has a positive strand RNA
genome encoding a single polyprotein that is cleaved by cellular
and viral proteases into 10 different proteins: core, E1, E2, p7,
NS2, NS3, NS4A, NS4B, NS5A and NS5B [3]. The non-
structural proteins NS3 to NS5B are involved in the replication of
the viral genome, whereas the structural proteins (core, E1 and E2)
are the components of the viral particle (reviewed in [4]). The
remaining proteins, p7 and NS2, are dispensable for RNA
replication and there is no evidence that they are part of the
viral particle [5,6].
For reasons still unknown, HCV clinical isolates do not
propagate in cell culture. However, with the development of a
cell culture system that enables a relatively efficient amplification
of HCV (HCVcc) [7,8,9], all the steps of the HCV life cycle can be
investigated. Due to the accumulation of HCV core protein
around lipid droplets (LDs) (reviewed in [10]), a role of these lipid
bodies in HCV assembly has been suspected for a long time.
Moreover, it has recently been shown that viral non-structural
proteins like NS5A and NS3 and double stranded viral RNA are
also present around LDs [11,12]. The association between core
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and LDs seems to play a role in the recruitment of the other viral
proteins and for virus production [12,13]. Furthermore, NS5A
plays a double role in both replication and assembly processes as a
potential switch between these two steps [14,15,16,17].
Since it is dispensable for HCV RNA replication and it does not
seem to be incorporated into viral particles [6], NS2 has been
suspected to be involved in the assembly process of HCV particle.
Recently, experimental evidence supporting this hypothesis has
been obtained [18,19,20]. Although the role of NS2 in the
assembly process remains elusive, some data suggest that NS2
might interact with viral partners involved in virion morphogen-
esis. Indeed, construction of chimeric viruses between different
genotypes identified the C-terminus of the first transmembrane
segment of NS2 as the optimum crossover point [21]. Thus, a
genetic interaction was implied between the N-terminus of NS2
and the upstream structural proteins. In the context of a chimeric
virus containing genotype 1a and 2a sequences, adaptive
mutations in E1, p7, NS2 and NS3 were identified, also suggesting
genetic interactions between these proteins [22]. Moreover, a
detailed rescue mutant analysis recently showed genetic interac-
tions between NS2, E1E2 and NS3-4A [23]. However, despite
these genetic analyses we have almost no understanding about
NS2 interactions with other viral proteins and the role of these
interactions in the production of infectious particles. Here, we
report molecular interactions between NS2 and p7 and E2
proteins. Using a functional HCVcc virus with a reporter epitope
at the N-terminus of NS2, we found that NS2 accumulates in
dotted structures derived from the endoplasmic reticulum (ER)
and colocalizes with E1, E2, NS3 and NS5A in close proximity to
the core protein and LDs. Mutations and deletions in the p7-NS2
region affecting the subcellular localization of NS2 and its physical
protein-protein interactions abolished viral assembly. Moreover,
mutations in other viral proteins reported to inhibit the assembly
process induced consistent changes in NS2 subcellular localization.
Together, these data suggest that p7, NS2 and E2 form a
functional unit which drives the proteins in the proximity of the
LDs where NS2 crosstalks with other viral proteins during the
virion assembly process.
Results
Mutation rationale in NS2
NS2 is a polytopic transmembrane protein containing 3 putative
transmembrane segments [19](Figure 1). The p7 polypeptide and
E1E2 heterodimer, which are putative partners of NS2, are also
membrane proteins that contain transmembrane segments
[24,25]. Due to their respective topologies (Figure 1A), it is
expected that interactions between these three proteins would
involve helix-helix contacts in their transmembrane segments.
Furthermore, helix-helix interactions between transmembrane
segments of NS2 are also likely to take place.
To analyze the role of the transmembrane domain of NS2 in
potential protein-protein interactions, we used a previously
reported deletion mutant of NS2 (DTM12) which lacks the first
two transmembrane segments [19]. For a more refined analysis,
we also used alanine scanning insertion mutagenesis, a technique
which has been shown to disrupt helix-helix interactions in a
membrane environment [26,27,28,29]. As illustrated in Figure 1C
for the first transmembrane segment of NS2, this approach is
based on the fact that insertion of a single amino acid into a
transmembrane helix displaces the residues on the N-terminal side
of the insertion by 110u relative to those on the C-terminal side of
the insertion. The subsequent perturbation of the residue side-
chain distribution could disrupt a potential helix-helix packing
interface involving residues on both sides of the insertion. Such
mutations are therefore expected to disrupt helix-helix interactions
between the transmembrane segments of NS2 and/or between
NS2 and other putative partners like p7 or E1E2.
Based on the NMR structure of the transmembrane segments of
NS2 [19](Jirasko et al., 16th International Symposium on HCV
and Related Viruses, Nice, October 3–7, 2009), we designed
insertion mutations in the transmembrane domain of NS2. Three
different mutants were designed by inserting alanine residues close
to the middle of the transmembrane segments of NS2 (Figure 1, B–
C). The positions for alanine insertions were carefully chosen
within the putative helical segments to preserve the overall fold of
the corresponding helices. According to previous reports
[26,27,28,29], alanine insertions near the center of putative
transmembrane helices were expected to be the most efficient to
disrupt inter-helices potential interactions.
NS2 transmembrane domain mediates E2-NS2
interaction
Firstly, we wanted to evaluate the impact of our mutations on
the viral life cycle. As negative controls for virus assembly, we used
assembly-deficient viruses JFH-DE1E2-HA and JFH-Dp7-HA,
containing a deletion in the regions encoding HCV envelope
glycoproteins and the p7 polypeptide, respectively (Figure S1). As
template for all our constructs, we used a full-length JFH1 plasmid
containing adaptive mutations [30] in which the N-terminal
sequence of E1 has been modified to reconstruct the A4
monoclonal antibody (Mab) epitope of the H77 isolate in order
to facilitate the immunodetection of this envelope protein [31].
Moreover, we introduced an HA epitope in the N-terminus of
NS2 to be used for protein detection (JFH-HA). Huh-7 cells were
electroporated with different mutated viral genomes and the
production of infectious virus was assessed at 72h by supernatant
titration (Figure 2A). The insertion of the HA epitope did not
affect the virus production as compared to the wild-type virus
(JFH). As previously reported, deletion of the first two transmem-
Author Summary
Hepatitis C virus (HCV) causes major health problems
worldwide. Understanding the major steps of the life cycle
of this virus is essential to developing new and more
efficient antiviral molecules. Virus assembly is the least
understood step of the HCV life cycle. Growing experi-
mental evidence indicates that, in addition to the physical
virion components, the HCV non-structural proteins are
intimately involved in orchestrating morphogenesis. Since
it is dispensable for HCV RNA replication, the non-
structural viral protein NS2 is suggested to play a central
role in HCV particle assembly. Molecular interactions
between NS2 and other HCV proteins were demonstrated.
Furthermore, NS2 was shown to accumulate over time in
endoplasmic reticulum-derived structures and to coloca-
lize with the viral envelope glycoproteins and viral
components of the replication complex in close proximity
to the HCV core protein and lipid droplets. Importantly,
specific mutations within NS2 that affected HCV infectivity
could also alter the subcellular localization of NS2 protein
and its interactions, suggesting that this subcellular
localization and its interactions are essential for HCV
particle assembly. Altogether, these observations indicate
that NS2 protein plays an important role in connecting
different viral components that are essential for virus
assembly.
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Figure 1. Rationale for mutagenesis in NS2 transmembrane region. (A) Schematic representation of the topology of E2, p7 and NS2 proteins.
(B) Position of the inserted alanine residues in the putative N-terminal membrane domain of NS2. Alignments of NS2 membrane domain sequences
from HCV strains JFH1 (genotype 2a, accession number AB047639) and Con1 (genotype 1b, AJ238799). Amino acids are numbered with respect to
NS2 and the HCV JFH1 polyprotein (top row). Second. struct., secondary structure deduced from the NMR analyses of NS2 synthetic peptides from
Con1 strain [19] (Jirasko et.al. the 16th international Conference on HCV and Related Viruses, Nice, October 3–7, 2009); c = coil, h = helix; capital letters
indicate canonical helix structure. Predicted TM, consensus transmembrane (TM) segment predictions were deduced from a set of 6 available web-
based algorithms prediction methods (DAS, TOPPRED2, TMHMM, SOSUI, TMPRED, PHD-TM) and represented by stretches of ‘‘T’’. Arrows indicate the
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brane segments prevented the production of infectious particles
similar to the negative controls [19] (Figure 2A and S1).
Furthermore, alanine insertions also drastically affected the viral
production. While mutants A16 and A41 presented residual
infectivity, A82 was not able to produce infectious particles
(Figure 2A).
To identify the stage where the virus production was affected,
we started with the evaluation of the replication capacity of our
viruses. To this aim, we used Renilla luciferase reporter viruses
(Figure S1A). As a negative control for replication, we used the
replication-deficient construct JFHGND-Luc which contains a
mutation in NS5B that prevents viral genome replication [7]. As
the RNA input after electroporation is potentially variable, we
evaluated the capacity of our viruses to replicate by determining
the ratio between the luciferase activity at 72h and 4h post-
electroporation when only the luciferase activity of the input RNA
is present as previously shown [32]. As shown in Figure S1B, all
the mutant viruses presented a similar replication capacity, which
was comparable to the control viruses, whereas replication was
abolished in the JFHGND-Luc mutant (Figure S1B-upper panel).
Since the replication was not affected, the effect of alanine
insertion on NS2 protein stability was further investigated. As
shown in Figure S1C, A82 insertion was detrimental for the
protein integrity. For A16 mutant, the level of expression of NS2
was slightly lower as compared to the JFH-HA control. However,
the level of expression of HCV proteins was higher for the JFH-
HA control in this particular experiment. We therefore measured
the NS2/E2 ratios which were similar for A16, A41 and JFH-HA,
indicating that A16 and A41 insertions did not affect NS2 stability.
Therefore, we focused our analysis on A16 and A41 mutants.
To test whether the lack of infectivity could be due to a defect
in virus secretion or the release of non-infectious particles, we
determined the level of core protein in the supernatants. The
quantity of core protein in supernatants decreased drastically as
compared to wild-type, paralleling the decrease in infectivity
(Figure 2B). It has to be noted that for the mutants showing a
residual infectivity (A16, A41 and RR/QQ), the release of core
was at the same level as the dead mutants (DTM12, A82 and
Dp7). This likely reflects a difference of sensitivity between the
two assays. Then, we measured the viral RNA in the
supernatants by qRT-PCR as previously described [17]. For all
the alanine insertions, the release of viral RNA was close to the
background level observed for the assembly-deficient control
viruses (Figure S1B – lower panel), indicating a defect in particle
secretion. These data suggest that either the process of assembly
is affected at an early stage or the secretion of assembled
infectious particles is impaired. To answer this question, we
compared the intra and extracellular level of the core protein
(Figure 2B). The ratio between intra and extracellular core was
similar to JFH-Dp7-HA which was shown to be defective in early
assembly steps. We also measured the intracellular infectivity of
the alanine mutants in the Rluc reporter viruses context as
previously reported [20]. As shown in Figure S1B (middle panel),
there was no accumulation of intracellular infectivity for any of
the mutants. These results suggest that mutations in the
transmembrane domain of NS2 prevent the assembly process
rather than the secretion of particles.
Considering the rationale of our mutagenesis, we investigated
protein-protein interactions in E1E2-p7-NS2 region. Indeed, due
to their position within the HCV polyprotein, it is reasonable to
think that these proteins might potentially interact. Genetic and
co-immunoprecipitation data suggest that NS2 interacts with E2
[23,32,33,34]. Interaction assays between NS2 and E2 were
performed in the context of the JFH-HA virus, which allows to
immunoprecipitate NS2 with the HA tag (Figure 2C, JFH-HA). As
shown in Figure 2C (JFH-HA), E2 and NS2 proteins migrated at
the expected molecular mass, indicating that the polyprotein was
correctly processed in these viruses. It has to be noted that in the
absence of p7, E2 migrated slightly faster. This is likely due to the
absence of E2-p7, which has a slightly slower migration profile in
the band corresponding to E2.
The E2-NS2 interaction was then tested by co-immunoprecip-
itation with an anti-HA antibody followed by the detection of E2
by Western blotting. As shown in Figure 2C (JFH-HA), E2 co-
precipitated with NS2, confirming that these proteins interact
together in the context of the virus. In contrast, deletion of the first
two transmembrane segments prevented the interaction between
NS2 and E2 (Figure 2C, DTM12), whereas alanine insertions in
the transmembrane region had different effects. While A16 (within
TM1) did not affect the E2-NS2 interaction, A41 (within TM2)
induced a consistent decrease in the amount of E2 co-precipitated
by NS2 (Figure 2C, A16 and A41).
We further investigated the effect of p7 on the E2-NS2
interaction. To this aim, we used two mutants of p7, a deletion
mutant (JFH-Dp7-HA) and a mutant having the two arginine
residues in the cytosolic loop of p7 replaced by glutamine residues
(JFH-RR/QQ-HA) (Figure 2C). This RR/QQ mutation is
believed to abolish the ion channel activity of p7, and it induces
a drastic decrease in virus production as previously reported
[32,35] and confirmed by us as shown in Figure 2A. As shown in
Figure 2C (JFH-Dp7-HA and JFH-RR/QQ-HA), E2 and NS2
proteins migrated at the expected molecular mass, indicating that
the polyprotein was correctly processed in these viruses. However,
the two mutations had no significant effect on E2-NS2 interaction
(Figure 2C JFH-Dp7-HA and JFH-RR/QQ-HA), suggesting that
p7 does not modulate E2-NS2 interaction.
NS2 accumulates in dotted structures
To obtain more insight into the assembly defects of our viral
mutants, we decided to determine their potential effect on the
subcellular localization of NS2. To this aim, we first characterized the
subcellular localization of the wild-type NS2 in the context of an
infectious virus, which has never been reported before. NS2
presented an ER-like reticulated pattern, and in some cells,
accumulated in dotted structures (Figure 3A and data not shown).
The number of these NS2-positive dot-like structures increased over
time, suggesting a transition from an initial reticulate pattern to these
dotted structures. At 72 hours post-electroporation, 34615% of
infected cells from 8 different electroporations displayed NS2 dots.
The size of these structures was 0.8460.38 mm (mean6SD, n = 402).
positions of the various alanine insertions. (C) Ribbon representations of the molecular homology model of NS2[1–27] of JFH1 (left) and the
theoretical model for alanine insertion mutant A16 (right). An Ala insertion (shown in magenta) twists the helix by 110u. The N-terminal part of the
model is shown in the same orientation as in the left model to highlight the distortion of residue positions on the C-terminal part of the helix. The
side chains of indicated residues are shown to highlight this distortion. These models were constructed by using the NMR structure of Con1 NS2[1–
27] ([19]; PDB entry, 2JY0) as template and the Swiss-PdbViewer program (http://www.expasy.ch/swissmod/). Residues are colored based on the
chemical properties of their side chains: hydrophobic (gray) and polar (yellow). Acidic (Asp) and basic (Arg, Lys) residues are red and blue, respectively.
His is cyan, and Gly is light gray. The membrane interfaces and hydrophobic core are schematically represented.
doi:10.1371/journal.ppat.1001278.g001
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To further characterize these NS2 structures, we performed co-
localization analyses with different cellular markers. As expected, the
reticulate and perinuclear pattern of NS2 overlapped with
calreticulin staining as well as other ER markers like calnexin and
PDI (data not shown). Interestingly, NS2 dots also colocalized with
ER markers (Figure 3B), but they did not colocalize with other
organelle markers of the secretory pathway (data not shown).
Importantly, NS2 dots were also found in close proximity of LDs
(Figure 3B), suggesting that they might play a role in HCV assembly.
To better understand the potential role of NS2 dots in virus
assembly, we analyzed the subcellular localization of NS2 in
relationship with the other viral proteins. NS2 dots overlapped
with HCV envelope glycoproteins E2 (Figure 3B) and E1 (Figure
S2). NS5A and NS3 were also shown to colocalize with NS2 in its
dotted pattern (Figures 3B and S2). Importantly, the structures
containing both NS2 and NS5A were observed in close proximity
to LDs (Figure 4A). This is illustrated by the presence of magenta
dots (red NS2 and blue NS5A) in the proximity of LD (green).
Finally, as observed with the LDs, NS2 dots were also found in
close proximity to core protein (Figure S2), and as expected this
association was observed in close proximity to LDs (Figure 4B). As
shown in Figure 4B, core (blue) is tightly associated to LD (green)
as the LD becomes cyan due to colocalization, NS2 (red) localizes
in regions juxtaposed to the cyan LD (Figure 4B). Relying on the
spatial proximity of NS2 dots, core, E1E2, NS3, NS5A proteins
and LDs, we speculated that NS2 present in these structures is
involved in the assembly process. Thus, we established some
criteria of functionality for NS2 positive structures. They have to
localize in the proximity of LDs and core protein and more
importantly to colocalize with NS5A protein, which we used as a
criteria for quantification purposes.
It has to be pointed out that a low number of cells contained
NS2-positive structures with a different pattern of subcellular
localization (Figure S3). This different pattern was indeed observed
in approximately 1 to 3% of the cells at 72h post-infection or post-
electroporation. These structures colocalized less with ER markers
and they overlapped with ERGIC-53, a marker of the ER-to-
Golgi intermediate compartment [36] (Figure S3). Furthermore,
these NS2 dots were detected in close proximity to the ER exit
sites, which were identified by markers of the COP II coatomer,
Sec31 and p125 [37,38] (Figure S3 and data not shown).
However, cells containing these NS2 positive structures showed
dramatic alterations of the secretory compartments as observed by
immunofluorescence analysis of ER-to-Golgi intermediate com-
partment and Golgi morphology using ERGIC-53 and GM130 as
markers (Figure S3). It is worth noting that NS2 did not colocalize
with NS3 or NS5A and it was not found in the proximity of core
and LDs in these cells (Figure S3). Due to these alterations, it is
unlikely that these cells are involved in the production of infectious
virus.
Figure 2. NS2 transmembrane region enables the NS2-E2
interaction. (A) Mutations in NS2 transmembrane region drastically
decrease the production of infectious virions. Huh-7 cells were
electroporated with viral RNA transcribed from different JFH-1 derived
mutants. At 72h post-electroporation, the virus infectivity present in the
supernatants was determined by titration of foci forming units (FFUs).
Error bars indicate SD from at least two independent experiments
performed in duplicate. A16, A41 and A82 correspond to JFH-HA virus
with an alanine residue inserted at position 16, 41 and 82 of NS2,
respectively. The following viruses were also analyzed in parallel: JFH-
DTM12-HA (DTM12), JFH-Dp7-HA (Dp7) and JFH-RR/QQ-HA (RR/QQ). (B)
The NS2 mutations affect the viral secretion, but not the replication
capacity. Huh-7 cells were electroporated with viral RNA transcribed
from different JFH-1 derived mutants. At 72h post-electroporation, the
amount of extracellular and intracellular core antigen was determined
in supernatants and cell lysates, respectively. Error bars indicate SD from
at least two independent experiments performed in duplicate. (C) HA-
NS2 co-immunoprecipitates with E2. Huh-7 cells were electroporated
with viral RNA transcribed from different JFH-1 derived mutants. At 72h
post-electroporation, cells were lysed and immunoprecipitation was
performed with an anti-HA antibody. The immunoprecipitates were
separated by SDS-PAGE and analyzed by Western blotting with an anti-
E2 antibody. The presence of E2, and HA-NS2 in electroporated cells
was confirmed by Western blotting and the actin content was also
analyzed to verify that equal amounts of cell lysates have been loaded.
It has to be noted that the E2 band corresponds to both E2 and E2p7
proteins. However, in the absence of p7, the E2-p7 form is absent.
doi:10.1371/journal.ppat.1001278.g002
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We asked further the relevance of NS2 dots for the production
of infectious particles. After electroporation, we determined the
titer of virus production at different time points (Figure 4C, upper
panel). In parallel, we counted the number of cells which presented
NS2/NS5A positive dots for reasons detailed above (Figure 4C,
lower panel). The kinetics of virion production and the percentage
of cells presenting NS2/NS5A positive dots showed a high
correlation with a correlation coefficient of 0.9. To exclude the
possibility that the NS2 phenotype depends on the cell culture
adaptive mutations, we performed a similar experiment with a
virus that does not contain the mutations. As for the adaptive
mutant, virus production in the absence of mutation paralleled the
NS2/NS5A dots formation with a significant correlation coeffi-
cient (data not shown). These data reinforce the idea that NS2/
NS5A positive dots are involved in the virus production process.
To further investigate the NS2 localization, we performed
immuno-electron microscopy with an anti-HA antibody on Huh7
cells which were electroporated with JFH-HA RNA and prepared
by cryosubstitution. As shown in Figure 4D, we could identify
clusters of gold particles in the proximity of LDs. Moreover, two of
the clusters are lying on preserved ER bilayers. For one of the
clusters of gold particles, a connection between the ER bilayer and
the LDs could be observed (Figure 4D). Thus, the immuno-
electron microscopy confirms the juxtaposition between NS2 dots
and LDs in a 0.2mm range, which is consistent with the
observations in confocal microscopy. It has to be noted that gold
particles were detected on both sides of the membrane even if the
HA epitope is supposed to be located in the ER lumen. This is
compatible with the length of two antibodies (primary+secondary)
since the gold particles were never further away than 30 nm from
the membrane. However, we cannot exclude a double topology for
NS2 as recently suggested [39].
NS2 transmembrane region is crucial for its subcellular
localization
The next obvious step was to determine the subcellular
localization of NS2 for the different mutants defective in assembly.
In the case of DTM12, NS2 localized in confined structures which
did not colocalize with NS5A and they were not associated with
the core protein or LD (Figure 5, panels A and C and data not
shown). Moreover, there was no colocalization between the
truncated NS2 and the E2 glycoprotein (Figure 5B), which
correlates with the lack of interaction between the two proteins
(Figure 2C). Then, we analyzed the subcellular localization of NS2
for the alanine insertion mutants. While A16 mutant presented
NS2 dotted structures as wild-type, A41 mutation induced a
drastic decrease in the percentage of cells with NS2 dots (Figure 5,
panels A and C). These data suggest that NS2 transmembrane
region is an important localization determinant.
Core, envelope and p7 proteins influence NS2 subcellular
localization
A peculiarity of the Flaviviridae family is the involvement of both
structural and non-structural proteins in the assembly process
(reviewed in [40]). Thus, we wanted to investigate the NS2
subcellular localization in the context of assembly deficient viruses
having mutations in different viral proteins.
Recruitment of core protein to LDs was reported to be essential
for a productive assembly process [12,13]. The proline residues
138 and 143 in domain D2 of the core protein are crucial for virus
production and core recruitment to LDs [13,41]. Furthermore, the
mutation of these proline residues has been previously shown to
prevent the core induced recruitment of NS5A to the LDs [12].
Therefore, we introduced these mutations in the context of JFH-
HA virus (Figure 6, JFH-HA-PP). As previously reported [13], the
mutation prevented the production of infectious virions
(Figure 9A), and the core protein was not redistributed to LDs,
which in turn remained spread in the cytoplasm rather than the
perinuclear localization induced by a functional core protein
(Figure S4). As shown in Figure 6, in the context of this mutation,
NS2 protein maintained the capacity to accumulate in dotted
structures that colocalized with NS5A. In contrast to the wild-type,
NS2 dotted structures were not found in the vicinity of LDs in the
context of the PP mutation, suggesting that NS2 does not have the
signals to localize by itself around the LDs (Figure S4).
Importantly, in this context, the number of cells presenting NS2
dotted structures increased tremendously in comparison to the
wild-type (Figure 6B). These observations suggest that the PP
mutation induces a block in the assembly process, which favors the
accumulation of NS2 protein in the dotted structures.
As structural proteins, the envelope glycoproteins are involved
in the assembly process [42]. The envelope proteins play a crucial
role in the assembly of enveloped viruses, which can be due for
some viruses to the capacity of the envelope proteins to establish
lateral interactions and to generate a pushing force necessary for
the budding process [43]. A deletion in the envelope region would
therefore block the assembly process as shown by an in-frame
deletion of 351 amino acids in the envelope proteins region [7]. In
the context of our JFH-HA virus, this deletion mutant is also fully
replicative, and it does not produce infectious particles (data not
shown). To further understand the interplay between NS2 and
HCV envelope glycoproteins, we analyzed the subcellular
localization of NS2 protein in the context of the E1E2 deletion.
In this context, NS2 localized in NS5A positive structures
juxtaposed to the LDs and core protein (Figure 6 and S4).
Interestingly, as for the JFH-HA-PP virus, the number of cells
presenting NS2 dotted structures also increased in the case of JFH-
DE1E2-HA, correlating also with a block in the assembly process
favoring an accumulation of NS2 dotted structures (Figure 6B).
The deletion introduced in the envelope region is predicted to
generate a chimeric protein comprising the N-terminus of E1 and
the C-terminus of E2 protein. Since we introduced the A4 epitope
in the N-terminus of E1, we were able to detect the subcellular
localization of this small chimeric protein. It is worth mentioning
that we also detected this truncated chimeric protein in NS2/
NS5A dotted structures, suggesting that the E2 transmembrane
domain is sufficient for the recruitment of HCV envelope proteins
to NS2 dotted structures (Figure S4).
The p7 protein has been shown to be crucial for the assembly
process [32,35]. Moreover, the ion channel activity of p7 correlates
Figure 3. Subcellular localization of NS2. (A) NS2 accumulates in dotted structures. Huh-7 cells electroporated with JFH-HA RNA were grown on
coverslips and fixed at 48h and 72h post-electroporation. The subcellular localization of HA-NS2 was analyzed by immunofluorescence using an anti-
HA antibody. (B) Colocalization of NS2 dotted structures with cellular and viral markers. JFH-HA electroporated cells grown on coverslips were fixed at
72h post-electroporation and processed for double-label immunofluorescence for HA-NS2 (red) and the ER marker calreticulin (CRT in green) or the
LDs stained with BODIPY 493/503 (green). JFH-HA electroporated cells were further stained for HA-NS2 (red) and HCV proteins NS3 or E2 (green). The
nuclei were stained with DAPI. Representative confocal images of individual cells are shown in grey and the merge images in color. Zoomed views of
the indicated areas are shown in the right column. Bar, 10 mm.
doi:10.1371/journal.ppat.1001278.g003
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Figure 4. NS2 colocalization with viral proteins in association with LDs. JFH-HA electroporated cells grown on coverslips were fixed at 72h
post-electroporation and processed for triple-label immunofluorescence for HA-NS2 (red), the LDs (green), and (A) NS5A or (B) core protein (C) (blue).
Individual confocal images of each labeling are shown in left panels, with a merged image of the three channels in the top left panel. Two by two
overlays are shown in right panels. A view of the entire cell is shown in the top right panel. Bar, 10 mm. (C) The kinetics of virus production for JFH-HA.
Huh-7 cells were electroporated with viral RNA transcribed from JFH-HA construct. At different time points post-electroporation, the virus infectivity
present in the supernatants was determined by titration of foci forming units (FFUs)(upper panel). Error bars indicate SE from at least two
independent experiments performed in duplicate. The kinetics of NS2/NS5A positive dots parallels virus production (lower panel). Huh-7 cells
electroporated with JFH-HA RNA were grown on coverslips and fixed at different time points post-electroporation and labeled with anti-HA and anti-
NS5A antibodies. The cells which presented at least 3 dots NS2/NS5A positive were considered positive for NS2 dotted structures. The results were
expressed as percentage of total counted infected cells. At least 300 infected cells were counted for each time point. Error bars indicate SE from at
least two independent experiments. (D) NS2 detection by immuno-EM microscopy. JFH-HA electroporated cells grown in 75 cm2 flasks were fixed at
72h post-electroporation and processed for immuno-electron microscopy labeling with anti-HA antibody. A representative image is shown where
three HA-NS2 clusters (arrows) could be observed in the proximity of a LD. Two of these clusters of gold particles (white arrows) are lying on well-
preserved ER bilayers. For one of these clusters of gold particles, a connection between the ER bilayer and the LD could be observed (white
arrowhead). A third cluster of gold particles (black arrow) is observed on a less preserved ER bilayer.
doi:10.1371/journal.ppat.1001278.g004
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with the virus assembly process since mutations predicted to abolish
the ion channel activity have a strong inhibitory effect on the virus
production [32,35]. We therefore also analyzed the subcellular
localization of NS2 in the context of p7 mutants corresponding to a
complete deletion (JFH-Dp7-HA) or an amino acid substitution
(JFH-RR/QQ-HA) previously reported to affect the assembly and
release of the virus [32,35]. The two constructs behaved as
expected. While JFH-Dp7-HA produced no infectious particles,
JFH-RR/QQ-HA presented a 2 log10 decrease in virus titers at 72h
post-electroporation (Figure 2A). Importantly, the two mutants
induced a drastic decrease in the number of cells presenting NS2/
NS5A dotted structures (Figure 6B). Together, these data indicate
that NS2 needs a functional p7 polypeptide to colocalize with NS5A
in dotted structures.
Other partners than p7 are likely necessary for NS2
accumulation in dotted structures. Indeed, as shown in Figure 5,
A41 and DTM12 mutants, which fail to interact with E2, also
present a drastically reduced number of NS2 dotted structures.
This suggests that NS2-E2 interaction might be crucial for NS2
subcellular localization. Thus, one additional determinant could
be represented by the transmembrane domain of E2, which is
most likely the interacting region with NS2 due to topological
constraints. In order to check this hypothesis, we used both JFH-
HA and JFH-DE1E2-HA constructs in which we replaced the
transmembrane region of E2 with the autoprotease 2A from foot
and mouth disease virus (FMDV) (JFH-DTME2-HA and JFH-
DE1E2TME2-HA)(Figure S1). We first verified that a proper
processing of the polyprotein mediated by FMDV 2A protease has
occurred in these constructs. To check our constructs, we analyzed
the molecular mass of E2 following deglycosylation with EndoH or
PNGase endoglycosidases. As shown in Figure 6C, E2 from JFH-
HA and JFH-DTME2-HA presented a similar molecular mass
after deglycosylation with EndoH, suggesting that the FMDV 2A
protease is functional since FMDV 2A and the transmembrane
domain of E2 have similar sizes. Indeed, if FMDV 2A protease
had not been functional, we would have observed a difference of
7kD corresponding to the molecular mass of unprocessed p7
(Figure 6C and data not shown). Interestingly, in contrast to the
wild-type envelope protein, the truncated E2 did not interact with
NS2 (Figure 6D). Furthermore, in contrast to what was observed
for JFH-HA and JFH-DE1E2-HA (Figure 6A), NS2 protein of the
DTME2 mutant presented an ER like pattern and the formation
of NS2 dotted structures was prevented (Figure 6A and B). Similar
data were also obtained with JFH-DE1E2TME2-HA construct
(Figure 6B). Thus, it seems that p7-NS2 and the transmembrane
domain of E2 form a functional unit that targets these proteins to
NS5A positive structures.
NS2 interacts with p7 in a co-immunoprecipitation assay
The above data suggest a possible interaction between p7 and
NS2. We therefore explored this putative interaction in a
biochemical assay, by analyzing p7-NS2 association in a co-
immunoprecipitation assay. Due to the difficulties in analyzing p7-
NS2 interactions in the context of an infectious virus, we analyzed
these interactions by co-transfecting cells with plasmids expressing
these two proteins only. In this approach, the p7 polypeptide and
NS2 were tagged with a Flag or a HA epitope, respectively
(Figure 7A, p7-Flag and HA-NS2).
The p7-NS2 interaction was tested after co-expression of the
tagged proteins in 293T cells. Co-immunoprecipitation experiments
were performed with an anti-Flag antibody linked to agarose beads.
The immunoprecipitates were separated by SDS-PAGE and
probed with anti-HA antibodies by Western blotting. As shown in
Figure 7B, NS2 of different genotypes coprecipitated with p7. Since
only p7 of genotype 1a was used in these experiments, it suggests
that p7 interacts with NS2 in a genotype independent manner.
However, we cannot exclude that the system is not sensitive enough
to discriminate between slight changes in affinities.
Further, we constructed two chimeric proteins, NS2 tagged with
a green fluorescent protein (NS2-GFP) and NS2-GTM (Figure 7A).
In NS2-GFP, the cytosolic domain of NS2 was replaced by GFP
protein, whereas for NS2-GTM, we replaced the transmembrane
domain of NS2 by the transmembrane domain of glycoprotein G
of VSV. As shown in Figure 7B, the NS2-GFP could be
precipitated by p7-FLAG, while NS2-GTM could not. This
clearly shows that the transmembrane region is the main
determinant of p7-NS2 interaction.
NS2 interacts with p7 in a fluorescence resonance energy
transfer with fluorescence lifetime imaging microscopy
(FRET-FLIM) assay
To confirm the p7-NS2 interaction with another approach, we
used the FRET-FLIM technique. FRET-FLIM requires the
presence of two fluorophores (a donor and an acceptor) fused in
frame to the studied proteins. If the two proteins interact, an
energy transfer occurs between the two fluorophores and the
fluorescence life time of the donor (a parameter of the energy
emitted by the donor) will decrease. To measure p7-NS2
interactions by FRET-FLIM, Cerulean fluorescent protein (CFP)
and Venus yellow fluorescent protein (YFP) were fused to the N-
terminus of p7 and NS2, respectively (Figure 8A).
As previously reported, CFP-p7 and YFP-NS2 showed a
reticulate perinuclear distribution (Figure 8B), which is character-
istic of ER proteins [34,44]. Western blotting analyses indicated
that CFP-p7 and YFP-NS2 migrate at the expected molecular
mass with some degradation products of lower molecular weight
(Figure 8C). The energy transfer in FRET-FLIM assay needs the
integrity of the fluorophores and the correct positioning of the
interacting partners. The degradation products could fall into two
categories: either soluble fluorophores or membrane bound
truncated chimeras. In either case the energy transfer is unlikely
to occur with the cleavage products. Thus, the presence of
degradation byproducts is unlikely to influence the accuracy of the
FRET-FLIM acquisitions.
After biphoton laser excitation and data analysis, fluorescence
life time maps were built. Interestingly, the regions showing
interactions were located in distinct spots throughout the cells as
Figure 5. Subcellular localization of NS2 mutants in TM region. (A) and (B) Effect of mutations on the accumulation of NS2 in dotted
structures. Huh-7 cells electroporated with JFH-HA RNA (WT) or mutant genomes were grown on coverslips and fixed at 72h post-electroporation.
The following viruses were analyzed: JFH-HA (WT), JFH-?TM12-HA (?TM12), JFH-A16-HA (A16) and JFH-A41-HA (A41). The subcellular localization of
HA-NS2 was analyzed by immunofluorescence using anti-HA (red), anti-NS5A (green) (Panel A) and anti-E2 (green) (Panel B) antibodies. The nuclei
were stained with DAPI. Representative confocal images of NS2 and NS5A labelings are shown in grey, and the merge images in color. Bar, 10 micro
mm. (C) Mutations in NS2 transmembrane region drastically decrease the number of cells presenting NS2 dotted structures. Huh-7 cells
electroporated with JFH-HA RNA were grown on coverslips and fixed at different time points post-electroporation and labeled with anti-HA and anti-
NS5A antibodies. Cells showing at least 3 NS2/NS5A dots were considered positive for NS2 dotted structures. The results were expressed as
percentage of total counted cells. At least 250 infected cells were counted. Error bars indicate SD from at least two independent experiments.
doi:10.1371/journal.ppat.1001278.g005
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illustrated in a fluorescence life time color-coded map (Figure 8D).
A summary of FRET-FLIM analysis is presented in Table 1. The
mean life time of fluorescence decreased from 2.6960.12 ns
(-
n = 10) in cells transfected with the donor only (CFP-p7) to
2.3460.09 ns (n = 10) for double transfections (CFP-p7+YFP-
NS2). The variation of the mean donor life time is characteristic
for energy transfer between two fluorescent proteins in FRET-
FLIM analyses as previously observed for other protein-protein
interactions [45,46]. As a positive control, we used the
transmembrane domains of HCV glycoproteins E1 and E2 which
are known to interact and to have the same subcellular localization
as p7 and NS2 [25]. The positive control couple presented a
comparable decrease in the mean lifetime of the donor to CFP-
p7/YFP-NS2 couple. Indeed, the mean life time decreased from
2.5660.03 ns (n = 14) in cells transfected with the donor only
(CFP-E2) to 2.3560.08 ns (n = 14) for double transfections (CFP-
E2+YFP-E1). As a negative control, we used CFP fused to the
transmembrane domain of yellow fever virus E protein (CFP-
EYF), a donor protein with the same topology and localization as
p7 [28,47]. As shown in Table 1, the mean life time of the donor in
monotransfection did not change in double transfections confirm-
ing the lack of interaction between CFP-EYF and YFP-NS2
(n = 11). The biphoton pictures for the positive and the negative
control are shown in Figure S5. Thus, these data strongly suggest
that p7 and NS2 proteins interact intracellularly.
NS5A stabilizes NS2 dotted structures
Among the non-structural proteins, NS5A is the most
characterized in terms of its role in the assembly process. NS5A
is recruited through direct interaction by the core protein around
LDs where its domain III is involved in the assembly process
potentially by its phosphorylation [14,16,17]. By deletion
mutagenesis, Tellinghuisen et al. identified a cluster of serine
residues at positions 452, 454 and 457, which are crucial for virus
production [17]. Furthermore, by alanine scanning mutagenesis,
Masaki et al. reported that the same serine cluster is involved in
the direct interaction between NS5A and core protein [16]. While
Tellinghuisen et al. reported that serine 457 alone is essential for
virus production, Masaki et al. showed that only double mutants
had a significant impact on virus production [16,17]. The
apparent contradiction might be explained by the different viruses
and time points for virus production assessment. While Tell-
inghuisen et al. used a chimeric virus consisting of the structural
proteins of J6 strain up to NS2 protein, Masaki et al. used the wild
type JFH strain [16,17]. Thus, we constructed the two mutants in
the context of our JFH-HA virus – JFH-S/A-HA and JFH-3BS/A-
HA, respectively. We analyzed the phenotype of the mutants as
well as the polyprotein processing. The results fitted the literature
with JFH-S/A-HA virus infectivity moderately reduced at 72h and
JFH-3BS/A-HA profoundly impaired in infectious virus produc-
tion, while the replication and protein integrity were unaltered
(Figure 9A, B, C). As reported, we showed that JFH-S/A-HA and
JFH-3BS/A-HA present less hyperphosphorylated NS5A
Figure 6. Subcellular localization of NS2 in assembly deficient mutants in the structural region. (A) Effect of mutations on the
accumulation of NS2 in dotted structures. Huh-7 cells electroporated with wild-type or mutant genomes were grown on coverslips and fixed at
72h post-electroporation. The subcellular localization of HA-NS2 was analyzed by immunofluorescence using anti-HA (red) and anti-NS5A (green)
antibodies. The nuclei were stained with DAPI. The following viruses were analyzed: JFH-HA (WT), JFH-Dp7-HA (Dp7), JFH-RR/QQ-HA (RR/QQ), JFH-
HA-PP (PP), JFH-DE1E2-HA (DE1E2) and JFH-DTME2-HA (DTME2). Representative confocal images of NS2 and NS5A labelings are shown in grey, and
the merge images in color. Bar, 10 mm. (B) Mutations in the structural region of HCV have different effects upon the number of cells presenting NS2
dotted structures. Huh-7 cells electroporated with JFH-HA RNA were grown on coverslips and fixed at different time points post-electroporation
and labeled with anti-HA and anti-NS5A antibodies. Cells showing at least 3 NS2/NS5A dots were considered positive for NS2 dotted structures.
The results were expressed as percentage of total counted cells. At least 220 infected cells were counted. Error bars indicate SD from at least two
independent experiments. In this experiment, JFH-DE1E2TME2-HA (DE1E2TME2) construct was used in addition to the above mentioned viruses.
(C) The transmembrane domain of E2 mediates the NS2-E2 interaction. Huh-7 cells were electroporated with viral RNA transcribed from JFH-HA or
JFH-DTME2-HA (DTME2) mutant. At 72h post-electroporation, cells were lysed and immunoprecipitation was performed with an anti-HA antibody.
The immunoprecipitates were separated by SDS-PAGE and analyzed by Western blotting with an anti-E2 antibody. Glycosylated or deglycosylated
lysates were blotted against E2 and HA-NS2. The actin content was also analyzed to verify that equal amounts of cell lysates have been loaded.
doi:10.1371/journal.ppat.1001278.g006
Figure 7. NS2 and p7 interact in a co-immunoprecipitation
assay. (A) Schematic representation of the constructs used in this
study. NS2-GFP corresponds to the transmembrane domain of NS2 in
fusion with GFP, whereas NS2-GTM corresponds to the transmembrane
domain of VSV-G protein in fusion with the cytosolic domain of NS2. All
the proteins contain a HA tag at their N-terminus. (B) HA-NS2 co-
immunoprecipitates with p7-Flag. 293T cells were transfected with
plasmids expressing p7-Flag, HA-NS2 from different genotypes, HA-NS2
mutants or control plasmids. At 24h post-transfection cells were lysed
and immunoprecipitations with an anti-Flag antibody were performed.
The immunoprecipitates were separated by SDS-PAGE and analyzed by
Western blotting with an anti-HA antibody to identify the presence of
co-immunoprecipitated HA-NS2. The presence of HA-NS2 in transfected
cells was confirmed by Western blotting. The actin content was also
analyzed to verify that equal amounts of cell lysates have been used.
doi:10.1371/journal.ppat.1001278.g007
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(Figure 9C). Surprisingly, for both mutants, NS2 localized mainly
in an ER-like pattern and the number of cells with NS2/NS5A
dots decreased dramatically (Figure 9D, E). The serine 457 may be
replaced by an aspartate residue, which mimics a phosphoserine
[17]. We therefore introduced the same mutation (JFH-S/D-HA)
and as reported the virus titers were restored at wild-type levels
(Figure 9A). Interestingly, this mutant partially recovered the NS2
subcellular localization both qualitatively and quantitatively
(Figure 9D, E). Together, these results suggest that NS5A
phosphorylation might stabilize the NS2 dotted structures in the
assembly process.
Discussion
Our understanding of the HCV morphogenesis process is still in
its infancy. Different viral components were identified as players in
the morphogenesis process. As expected, the structural proteins
are essential in the virus makeup [7]. The scenario gets more
complicated with the involvement of non-structural proteins in the
assembly process. The p7 polypeptide, NS2, NS3, NS4B, NS5A
were reported to be involved in viral assembly
[14,17,20,22,32,48]. However, the mechanism of the complex
interplay between the structural and non-structural proteins
towards the virion production is not understood. In this paper,
we provide evidence for molecular interactions between NS2, p7
and E2, respectively. Furthermore, we show that NS2 accumulates
over time in ER-derived dotted structures and colocalizes with the
envelope glycoproteins and components of the replication complex
in close proximity to the core protein and LDs. Characterized
assembly deficient mutants in both structural and non-structural
proteins present qualitative and quantitative modifications in NS2
Figure 8. NS2 and p7 interact in FRET-FLIM analyses. (A) Schematic representation of the constructs used in this study. (B)
Immunofluorescence analysis of the co-expression of CFP-p7 and YFP-NS2. U2OS cells were co-transfected with plasmids expressing CFP-p7 and
YFP-NS2. At 24h post-transfection, the subcellular localization of the different proteins was assessed by confocal microscopy. (C) Western blot analysis
of the expression of CFP-p7, YFP-NS2 and CFP-EYF. U2OS cells were transfected with plasmids expressing CFP-p7, YFP-NS2 or CFP-EYF. At 24h post-
transfection, cells were lysed and protein expression was confirmed by SDS-PAGE followed by Western blotting. (D) FLIM analyses. Samples were
subjected to FLIM and color coded maps were obtained. The regions where the FRET events are present are marked with squares. The colors
represent the progression from minimum (yellow) to maximum (blue) fluorescence lifetime.
doi:10.1371/journal.ppat.1001278.g008
Table 1. Mean values of the fluorescence lifetime.
Proteins The mean lifetime of the donor protein (ns)
CFP-p7 2.69+/20.12
CFP-p7+YFP-NS2 2.34+/20.09*
CFP-E2 2.56+/20.03
CFP-E2+YFP-E1 2.35+/20.08*
CFP-EYF 2.59+/20.02
CFP-EYF+YFP-NS2 2.59+/20.06
*p,0.005. The statistical significance of the results was determined by using
the Student’s t-test after testing the normal distribution of the data with the
Shapiro-Wilk test [68].
doi:10.1371/journal.ppat.1001278.t001
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Figure 9. Subcellular localization of NS2 in assembly deficient mutants in NS5A protein. (A, B) Phenotype of the NS5A mutants. Virus
infectivity (A), extra (black bars) and intracellular (light grey bars) core determination (B) were performed as described in Figure 2. The following
viruses were analyzed: JFH-HA (WT), JFH-S/A-HA (S/A), JFH-3BS/A-HA (3BS/A) and JFH-S/D-HA (S/D). In addition, JFH-HA-PP (PP) was also analyzed in
parallel. (C) Analysis of the expression and phosphorylation of the NS5A mutants. The hyperphosphorylated form of NS5A is indicated by an asterisk.
The presence of core and NS5A was confirmed by Western blotting and the actin content was also analyzed to verify that equal amounts of cell
lysates have been loaded. (D) Effect of mutations on the accumulation of NS2 in dotted structures. Huh-7 cells electroporated with JFH-HA RNA (WT)
or mutant genomes were grown on coverslips and fixed at 72h post-electroporation. The subcellular localization of HA-NS2 was analyzed by
immunofluorescence using anti-HA (red) and anti-NS5A (green) antibodies. The nuclei were stained with DAPI. Representative confocal images of NS2
and NS5A labelings are shown in grey, and the merge images in color. Bar, 10 mm. (E) Mutations in NS5A protein drastically decrease the number of
cells presenting NS2 dotted structures. Huh-7 cells electroporated with JFH-HA RNA or the indicated mutants were grown on coverslips, fixed at 72 h
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subcellular localization. Indeed, specific mutations within NS2, p7
or E2 modify the subcellular localization of NS2 and impair virus
production. Mutations in core, envelope proteins or NS5A affect
the NS2 subcellular localization along with the virus titers.
Altogether, these observations indicate that NS2 protein crosstalks
with both structural and non-structural proteins during virus
assembly.
Our data demonstrate a physical interaction between NS2 and
p7. This interaction correlates with the previously reported genetic
interactions present in the C-NS2 region [21,22]. The HCV p7
polypeptide is a viroporin involved in viral assembly [20,32,49].
Viroporins represent a class of viral proteins that are involved in
the viral morphogenesis process in different and largely unknown
manners. Alphavirus 6K interacts with E1 and p62 envelope
glycoproteins and is involved in optimal assembly and release of
the virion by an unknown mechanism [50,51]. The E protein of
coronaviruses interacts with the M protein and is crucial for the
assembly of virus-like particles and virions [52,53,54]. To our
knowledge, the HCV p7 polypeptide is the first viroporin which
interacts with a non-structural protein (NS2) and this might be a
peculiarity of the members of the Flaviviridae family where the non-
structural proteins are involved in particle assembly [40].
Topologically, the transmembrane domain of NS2 (NS2TM)
would be the main region available for interactions with the
upstream transmembrane proteins p7 and E1E2. Based on this
assumption, we wanted to characterize NS2 interactions with p7
and E2 by deletion and chimeric mutants. Both NS2-E2
interaction and NS2-p7 interaction were mapped in the
transmembrane region of NS2 as expected. However, since the
lack of p7 does not affect the E2-NS2 interaction, we could
imagine that NS2 uses separate domains to interact with p7 and
the envelope proteins. Interestingly, when we deleted the
transmembrane region of E2, the NS2-E2 interaction was
impaired and the NS2 subcellular localization changed. Altogeth-
er, these observations suggest that p7, the transmembrane domain
of NS2 and the transmembrane domain of E2 contain signals
which act synergistically to direct the NS2 protein towards the
NS5A positive membranes in the LD proximity.
The drastic effects of alanine insertion mutagenesis on HCV
infectivity reflect more intrinsic effects on NS2 function in virus
assembly. As shown for lactose permease, single alanine residue
insertions into transmembrane helices of a polytopic membrane
protein can be highly disruptive to protein structure and function
due to their effects on intramolecular helix-helix interactions [26].
Furthermore, within the same protein, different transmembrane
helices can have differential sensitivities to single residue insertions
[26]. In the case of NS2, our data indicate that an insertion in the
third putative transmembrane helix strongly reduces the stability
of the protein, suggesting a drastic alteration of NS2 structure by
this mutation. The decrease in infectivity for the mutations in the
first two transmembrane helices also indicates a drastic alteration
in NS2 function that can be linked to local alteration of its
structure, as suggested by the change in subcellular localization of
NS2 mutant A41. Finally, the drastic decrease in infectivity of
mutant A16 in spite of NS2 localization in dotted structures
indicates that the subcellular localization of NS2 in these structures
is not sufficient by itself for infectivity. Rather, it likely needs to
play additional function(s) at the site of virus assembly and such
function(s) would be disrupted by the A16 mutation. One
explanation could be that a weak E2-NS2 interaction as seen for
A41 is not able to direct the p7-NS2 unit to the LDs and a
potential strong interaction as for A16 does not allow the p7-NS2
unit to release the envelope proteins heterodimer to the assembly
site and the subsequent recycling/dissociation of the unit.
Over time, a substantial part of NS2 accumulates in dotted
structures localized in the ER in close proximity to the core protein
which is associated to LDs. Since the LD/ER interface is
considered as the potential particle assembly site [12], NS2
localization close to the LDs is expected to correlate with its
function in a late step of the viral life cycle. Interestingly, NS2
accumulation in dotted structures parallels the colocalization of
NS2 with NS5A, NS3 proteins and most likely the replication
complex. Moreover, the NS2 dotted structures are juxtaposed to
the core protein and colocalize with the envelope proteins E1 and
E2. Thus the NS2 dots contain all the assembly players and are
located in the microenvironment of the LDs, the proposed virus
assembly site. It is worth mentioning that the formation of NS2
dotted structures is not due to a non-specific effect of the viral
genome replication since some of our mutants showing the same
replication rate had very different subcellular localizations of NS2
(e.g. A16 vs. A41). It seems rather that the formation of NS2
related dots represents a transition rather than an end state in a
productive assembly process. Indeed, mutations in core (JFH-HA-
PP) or in the envelope proteins (JFH-DE1E2-HA) induced an
obvious increase in the number of cells presenting NS2 dots. This
could mean that the p7-NS2-E1E2 complexes pre-exist in the
NS5A positive subcompartment. In addition, the core-mediated
redistribution of LDs could induce the recruitment of the assembly
components to LDs followed by the envelope protein incorpora-
tion into the virion during the budding process. Finally, after
budding, NS2 might relocate to another subcellular compartment
or be degraded. This scenario is supported by the fact that NS2
dots accumulate around the LDs and core protein when the
envelope proteins are deleted, which is expected to inhibit the
lateral interactions between the envelope proteins [42], preventing
the budding process to occur.
For the moment, the connection between NS2 and the
replication complex (RC) is just inferred from genetic data and
colocalization in immunofluorescence experiments [23,34](this
report). We show here that mutations in NS5A, which are
reported to affect the phosphorylation status of the protein, abolish
the accumulation of NS2 in dotted structures. Moreover, we could
partially restore the phenotype by an aspartate mutant, which
mimics phosphoserine. Thus, NS2 colocalization with NS5A is
favored by the phosphorylation state of the latter. It is possible that
NS5A charged state enhances a potential NS2-RC interaction,
which translates in NS2 dot formation. Removing the charges
would shift the interaction equilibrium and would affect the virus
production kinetics in different extents depending on the number
of charges and virus strain. Hence, if serine 457 is replaced, the
virus titers are moderately reduced at 72h. In contrast, removing
serine residues 452, 454, 457 determines a profound defect in
infectious virus production. However, there is no NS2 accumu-
lation for either of the two mutants. Thus, the NS2 dots may
represent transition states in the assembly process. Indeed, some
mutations may prevent the arrival of dots components to NS5A
structures (JFH-DTM12-HA, JFH-A41-HA, JFH-Dp7-HA and
JFH-DTME2-HA). Alternatively, other mutations may block the
post-electroporation and labeled with anti-HA and anti-NS5A antibodies. Cells showing at least 3 dots NS2/NS5A positive were considered positive
for NS2 dotted structures. The results were expressed as percentage of total counted cells (at least 228). Error bars indicate SD from at least two
independent experiments.
doi:10.1371/journal.ppat.1001278.g009
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assembly and stabilize them (JFH-HA-PP, JFH-DE1E2-HA). If we
combine a mutation from the former category (JFH-DTME2-HA)
with one from the latter (JFH-DE1E2-HA) in the mutant JFH-
DE1E2TME2-HA, we prevent the NS2 dots formation. This
suggests that the formation of NS2 complexes and their arrival to
the NS5A structures precede the accumulation of NS2 around the
LDs during the assembly process. Furthermore, changes in the
phosphorylation state of NS5A could regulate the stability of NS2
dots and virion production efficacy.
In our current view, the assembly process would involve several
steps. Upon viral genome translation and polyprotein processing,
formation of different complexes occurs: the E1E2 native
heterodimer, the p7NS2 unit and the RC. The core protein and
other viral proteins (e.g. NS4B) create the LD-ER microenviron-
ment by redistribution of the LDs and intracellular membranes.
The LDs surrounded by core protein are recruited to the RC.
E1E2 complex interacts with p7NS2 unit and E1E2p7NS2 arrives
to NS5A positive membranes in the proximity of LDs due to a
combination of signals in p7, NS2 and E2 proteins. NS5A switches
from the replication to assembly mode by phosphorylation, which
stabilizes the presence of NS2 in dotted structures favoring the
assembly process (Figure 10). Finally, our data indicate a crucial
role played by NS2 in the assembly process and highlight the
complexity of the mechanism of its action. In conclusion, NS2
emerges as an essential mediator between the structural and non-
structural proteins in HCV assembly process.
Materials and Methods
Cell culture
293T human embryo kidney cells (HEK293T), U2OS human
osteosarcoma cells (American Type Culture Collection) and Huh-
7 human hepatoma cells [55] were grown in Dulbecco’s modified
essential medium (Invitrogen) supplemented with 10% fetal bovine
serum.
Antibodies
Anti-HCV Mabs A4 (anti-E1) [56] and 3/11 (anti-E2; kindly
provided by J.A. McKeating, University of Birmingham, UK) [57]
were produced in vitro by using a MiniPerm apparatus (Heraeus) as
recommended by the manufacturer. Anti E2 Mab AP33 was
kindly provided by A. H. Patel, University of Glasgow, UK. Anti-
capsid ACAP27 [58] and anti-NS3 (486D39) Mabs were kindly
provided by JF Delagneau (Bio-Rad, France). The anti-NS5A
Mab 9E10 [8] and polyclonal antibody were kindly provided by
CM Rice (Rockefeller University, NY, USA) and M Harris
(University of Leeds, UK), respectively. The anti-NS2 Mab 6H6
[18] and polyclonal antibody were kindly provided by CM Rice
(Rockefeller University, NY, USA) and R Bartenschlager (Uni-
versity of Heidelberg, Germany), respectively. The anti-Sec31
antibody [38] was kindly provided by F Gorelick (Yale University
School of Medicine, CT, USA). The anti-p125 Mab [37] was
kindly provided by K Tani (University of Tokyo, Japan). The
following antibodies were purchased: the anti-ERGIC-53 Mab
(Alexis), the anti-actin (Santa Cruz Biotechnology), anti-calnexin
polyclonal (Stressgen), anti-calreticulin polyclonal (Stressgen), anti-
PDI (Stressgen), anti-GFP (Roche) and the anti-hemagglutinin
(HA) Mab 3F10 (Roche) and Mab HA11 (Covance). Alexa 488,
Alexa 555 and Alexa 633 conjugated goat anti–rabbit, anti-rat and
anti-mouse immunoglobulin G (IgG) were purchased from
Invitrogen.
Plasmids
All plasmids were constructed by standard molecular biology
methods and the constructs were confirmed by sequencing. The
following plasmids were assembled for FRET-FLIM analyses in
the background of pCMV plasmid (Addgene): pCMV/YFP-
E1TM, pCMV/CFP-E2TM, pCMV/CFP-p7, pCMV/CFP-
EYF, pCMV/YFP-NS2. For these constructs, the plasmids
encoding YFP and CFP were obtained from DW Piston
(Vanderbilt University, USA) and A Miyawaki (Riken Institute,
Japan), respectively. YFP-E1TM and CFP-E2TM are YFP and
CFP in fusion with the transmembrane domain of E1 and E2 (H
strain), respectively. In these two constructs, a two amino acid
linker (serine and glycine) was inserted between the fluorescent
protein and the transmembrane domains. CFP-p7 and CFP-EYF
are CFP proteins fused to the N-terminus of p7 and the
transmembrane domain of yellow fever virus envelope protein E
(EYF), respectively. YFP-NS2 is a YFP protein fused to the N-
terminus of NS2. In all the constructs, the calreticulin signal
sequence was fused to the N-terminus of CFP and YFP for
translocation in the ER lumen, allowing the study of the
recombinant proteins in their native topology.
For p7-NS2 co-immunoprecipitation experiments, the following
plasmids were constructed in the background of pTriex (Novagen)
or pCI plasmids (Promega): pTriex/p7-Flag, pTriex/EYF-Flag,
pCI/HA-NS2, pCI/HA-NS2-GFP and pCI/HA-NS2-GTM. p7-
Flag and EYF-Flag are HCV p7 of genotype 1a (H strain) and
YFE in fusion with the Flag epitope (DYKDDDDK). HA-NS2 has
a HA epitope fused to the N-terminus of NS2. In HA-NS2-GFP,
the cytosolic domain of NS2 was replaced by GFP protein,
whereas for HA-NS2-GTM, we replaced the transmembrane
domain of NS2 by the transmembrane domain of VSV-G protein.
In this work, we used a modified version of the plasmid encoding
JFH1 genome (genotype 2a; GenBank access number AB237837),
kindly provided by T. Wakita (National Institute of Infectious
Diseases, Tokyo, Japan) [7]. Mutations were introduced in a JFH1
plasmid containing a Renilla Luciferase reporter gene [59] and
mutations leading to amino acids changes F172C and P173S which
have been shown to increase the viral titers [30]. Furthermore, the
Figure 10. Model of NS2 role in the assembly process. Upon viral
polyprotein translation and processing, three viral modules are formed:
the core protein (C), the replication complex (RC) and the E1E2p7NS2
complex. E1E2p7NS2 complex assembles through the interaction of
E1E2 heterodimer and p7NS2 unit (4) and migrates close to the RC
independently of core protein due to signals present in p7NS2 and E2
(3). The core protein localizes around the LDs (1) where it recruits the RC
by core-NS5A interaction (2).
doi:10.1371/journal.ppat.1001278.g010
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E1 sequence encoding residues 196TSSSYMVTNDC has been
modified to reconstitute the A4 epitope (SSGLYHVTNDC) [56] as
described [31]. Overlapping PCR was used to construct all the
JFH1 mutants. The JFHGND-Luc construct was obtained by
inserting the previously described GND mutation [7] in JFH-Luc
plasmid. The JFH-HA construct was obtained by inserting the
sequence of the HA epitope (YPYDVPDYA) followed by a GGG
linker at the N-terminus of NS2. The JFH-Dp7-HA keeps the first 2
amino acids of p7 followed by the HA tag sequence and the SGG
linker at the N-terminus of NS2. The JFH-DE1E2-Luc plasmid has
been described previously [31]. It contains an in-frame deletion of
amino acids 217–567. JFH-DTM12-HA has the first two trans-
membrane segments of NS2 deleted as described [19], in the
context of our JFH-HA virus. JFH-HA-PP has proline residues 138
and 143 in domain D2 of the core protein replaced by alanine
residues as described [13,41]. JFH-S/A-HA has serine 457 of NS5A
replaced by an alanine as described [17]. JFH-3BS/A-HA has
serine residues at positions 452, 454 and 457 of NS5A replaced by
alanine residues as described [16]. The JFH-S/D-HA has serine
457 of NS5A replaced by an aspartate residue as described [17].
JFH-DTME2-HA and JFH-DE1E2TME2-HA have the transmem-
brane region of E2 glycoprotein replaced by FMDV 2A
autoprotease. JFH-DTME2-HA contains an in-frame deletion of
amino acids 720–750, corresponding to the transmembrane domain
of E2 of JFH1, whereas JFH-DE1E2TME2-HA contains in-frame
deletions of amino acids 217–567 and 720–750. To construct the
JFH-DTME2-HA, we replaced the C-terminal region of E2 (aa
720–750 of JFH1) by QLLNFDLLKLAGDVESNPGP FMDV 2A
autoprotease peptide preceded by a GGG linker sequence. A similar
strategy was used for the construction of JFH-DE1E2TME2-HA
using as a backbone plasmid the JFH-DE1E2-HA. JFH-RR/QQ-
HA has the arginines 33 and 35 of p7 replaced by glutamine
residues. The primers and enzymes used for the constructs are
presented in Table S1. Schematic representation of the constructs
used in this study is presented in Figure S1.
DNA transfections
Twenty-four hours before transfection, 293T cells were seeded
in 100 mm tissue culture plates to reach a 70–80% confluency the
next day. Cells were tranfected with 6 mg of DNA/plate at a ratio
of 1:4 with PEI transfection reagent (Eurogentec). In cotransfec-
tion experiments, equal quantities of each plasmid were used. At
24h post-transfection, cells were processed for co-immunoprecip-
itation analyses.
Twenty-four hours before transfection, U2OS cells were seeded
in 6 well plates on 32mm slides to reach a confluency of 70–80%
the next day. Cells were transfected with 1mg of CFP-expressing
plasmid (donor) and 125 ng of YFP-expressing plasmid (acceptor)
mixed with Fugene reagent (Roche) following the instructions of
the manufacturer. For CFP-E1 and YFP-E2 co-transfection
experiments, we used 300 ng of donor and 600 ng of acceptor
plasmids, respectively.
Two-photon fluorescence lifetime microscopy and data
analysis (FRET-FLIM)
Twenty-four hours after transfection, U2OS cells were selected
for FRET-FLIM acquisition. We analyzed cells with similar
expression levels of donor and acceptor fusion proteins. We also
chose cells with normal reticulate ER morphology avoiding those
where the overexpression of recombinant proteins was present.
In order to detect the FRET events, the Time Correlated Single
Photon Counting FLIM system (TCSPC) was used [60,61,62].
The analyses were performed with a Leica SP5.X confocal
Microscope (Leica Microsystem) with an internal FLIM detector.
A dedicated photo-counting and timing electronic card (SPC 830
TCSPC card, Becker and Hickl) was coupled to the Leica internal
detector and used to classify the photon emission in time to
determine the lifetime of the donor protein. To excite the samples,
Chameleon Ultra2 (Chorent Inc) biphoton was used at 830 nm at
an average power of 0.13 mW/mm2 [60,61,62].
The fluorescence events of the donor protein result in a photon
decay curve generated by the FLIM method. The decay curve was
directly used to determine the donor’s lifetime. The least square
fitting method was used to describe the non linear responses
commonly observed in FLIM analysis [60,61,62]. We used
TITAN (‘‘in the house’’ designed) and SPCImage (Becker and
Hickl) software for advanced FLIM data analysis and curve
fittings. In order to reduce the impact of background and improve
the Signal to Noise Ratio (SNR), we excluded from our analysis
the pixels located in the nuclear region or from ER-like regions
where the donor protein was overexpressed. After setting these
thresholds, we made a summation of all the pixels of interest to
achieve a fitting statistically significant for the TITAN software.
To compensate the possible large scattering of points in the curve,
we used a Newton trust region algorithm [63] and an extraction of
mean lifetimes was performed in order to determine the FRET
events from the multi-exponential model [64].
Immunoprecipitation
Cell pellets were lysed in phosphate-buffered saline (PBS) lysis
buffer (1% Triton 100-X, 20mM NEM, 2mM EDTA, protease
inhibitors cocktail Roche) and they were precleared with 20 ml
Prot G for 2h at 4C. The precleared lysates were incubated with
anti-HA antibodies (HA11) or Sepharose beads covalently bound
to HA11 antibody (Covance) overnight at 4h. The immunocom-
plexes were pulled down with 50 ml of Protein G and washed three
times with lysis buffer.
For p7-NS2 interaction, cell lysates were incubated with 20 ml of
agarose-anti-Flag beads over night at 4uC. The immunocomplexes
were treated the same as above and the Western blots were
revealed by an anti-HA antibody.
PNGase and EndoH digestion
The endoglycosidase digestions were performed following the
manufacture’s instructions (NEB). Briefly, cell lysates containing
20 mg of protein were denatured in EndoH (PNGase) denaturing
buffer (0.5% SDS, 1% 2-mercaptoethanol) for 10 min at 100uC.
Then, the lysates were incubated or not with 1 ml of EndoH
(PNgase) for 20h at 37uC.
Western blotting
After separation by SDS-PAGE, proteins were transferred to
nitrocellulose membranes (Hybond-ECL, Amersham) by using a
Trans-Blot apparatus (Biorad) and revealed with specific antibod-
ies followed by secondary immunoglobulin conjugated to perox-
idase. The proteins of interest were revealed by enhanced
chemiluminescence detection (ECL, Amersham) as recommended
by the manufacturer.
Replication and infectivity assays
Plasmids encoding wild-type (WT) and mutated genomes were
linearized at the 39 end of the HCV cDNA with the restriction
enzyme XbaI and treated with the Mung Bean Nuclease (New
England Biolabs). In vitro transcripts were generated using the
Megascript kit according to the manufacturer’s protocol (Ambion).
The in vitro reaction was set up and incubated at 37uC for 4 h and
transcripts were precipitated by the addition of LiCl. Ten
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micrograms of RNA were delivered into Huh-7 cells by
electroporation as described previously [30]. Replication was
assessed at 72 h by measuring Renilla Luciferase activities in
electroporated cells as indicated by the manufacturer (Promega).
Supernatants containing HCVcc were harvested 72 h after
electroporation and filtered through 0.45 mm pore-sized mem-
brane for infectivity measurements. HCVcc were incubated for
3 h with Huh-7 cells seeded the day before in 24-well plates. At
72 h post-infection, Luciferase assays were performed on infected
cells as indicated by the manufacturer (Promega). For supernatants
titration, Huh7 electroporated cells were seeded in 6-well plates.
72h post-electroporation, naı¨ve Huh-7 cells were inoculated with
serial dilutions of the supernatant. 48h post-inoculation, the
infected cells were fixed in ice-cold methanol, they were
immunostained with anti-E1 antibody and the focus forming units
(FFUs) were counted.
HCV Core quantification
HCV Core was quantified by a fully automated chemilumines-
cent microparticle immunoassay according to manufacturer’s
instructions (Architect HCVAg, Abbott, Germany) [65,66]. For
the determination of intracellular core quantity, the electroporated
cells were lysed in PBS lysis buffer (1% Triton 100-X, 20mM
NEM, 2mM EDTA, protease inhibitors cocktail Roche) and the
lysates were cleared for 20 min at 14,000g.
HCV RNA quantification
Mutated HCV genomes were delivered into Huh-7 cells. At day
3 post-electroporation, cells were trypsinized, washed once with
fresh medium and reseeded into cell culture dishes. At day 5 post-
electroporation, total RNA in cell lysates and HCV RNA in
supernatants were extracted using the Qiagen RNeasy kit and
Qiagen QiaAmp viral RNA mini kit, respectively. cDNA was
synthesized using High Capacity cDNA Reverse Transcription kit
as described by the manufacturer (Applied BioSystems) and
titrated by quantitative real-time RT-PCR assay (RT-qPCR) using
TaqMan and minor groove binding (MGB) probe detection. The
primer pair and the probe were located in the 59 HCV non-coding
region [67].
Immunofluorescence
Huh-7 cells transfected with HCV RNA were grown on 12-mm
glass coverslips. At the indicated time points, cells were fixed with
3% paraformaldehyde and then permeabilized with 0.1% Triton
X-100 in PBS. Both primary- and secondary-antibody incubations
were carried out for 30 min at room temperature with PBS
containing 10% goat serum. LDs were stained for 10 minutes in
300 ng/ml BODIPY 493/503 (Invitrogen). Nuclei were stained
with 4,69-diamidino-2-phenylindole (DAPI). The coverslips were
mounted on slides by using Mowiol 4–88 (Calbiochem) containing
mounting medium. Confocal microscopy was performed with an
LSM710 laser-scanning confocal microscope (Zeiss) using a 636/
1.4 numerical aperture oil immersion objective. Signals were
sequentially collected by using single fluorescence excitation and
acquisition settings to avoid crossover. Images were processed
using Adobe Photoshop software. Cells showing NS2/NS5A-
positive dot-like structures were counted on images collected with
a 406 oil immersion objective.
Immunoelectron microscopy
Huh-7 cells transfected with HCV RNA were grown on 75 cm2
flasks. At 72h post-electroporation, cells were fixed by incubation
in a solution containing 4% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.2) for 20 h. The cells were collected by
centrifugation and the cell pellet was then dehydrated in a graded
series of ethanol solutions at 220uC, using an automatic freezing
substitution system (AFS, Leica), and embedded in London Resin
Gold (LR Gold, Electron Microscopy Science). The resin was
allowed to polymerize at 225uC, under UV light, for 72 h.
Ultrathin sections were cut and blocked by incubation with 3%
fraction V bovine serum albumin (BSA, Sigma) in PBS. They were
then incubated with anti-HA Mab (Covance) diluted 1:50 in PBS
supplemented with 1% BSA, washed and incubated with goat
anti-mouse antibodies conjugated to 15 nm gold particles (British
Biocell International, Cardiff, UK) diluted 1:40 in PBS supple-
mented with 1% BSA. Ultrathin sections were cut, stained with
5% uranyl acetate, 5% lead citrate, and placed on electron
microscopy grids coated with collodion. The sections were then
observed with a Jeol 1230 transmission electron microscope
(Tokyo, Japan) connected to a Gatan digital camera driven by
Digital Micrograph software (Gatan, Pleasanton, CA) for image
acquisition.
Supporting Information
Figure S1 Mutations in NS2 affect viral assembly. (A) Schematic
representation of the constructs used in this study. (B) Character-
ization of the phenotypes of HCV mutants. Huh7 cells were
electroporated with the indicated genomes. At 72h post-electro-
poration supernatants were collected and cells were lysed.
Replication was determined as the ratio between Rluc counts at
72h and 4h, respectively (see Replication panel). In parallel, virus-
producing cells were washed and lysed by repetitive cycles of
freeze and thaw. Extracellular (black bars) and intracellular (white
bars) infectivities were determined by inoculating naı¨ve cells and
measuring the Rluc activities at 72h post-inoculation (see
Infectivity panel). To measure viral secretion, mutated HCV
genomes were delivered to Huh-7 cells. At two days post-
electroporation, cells were trypsinized, washed once and reseeded
into cell culture dishes. HCV RNA levels in cell lysates and in
supernatants were extracted 5 days after electroporation, and
titrated by quantitative real-time RT-PCR (see Secretion panel).
Viral secretion was considered equivalent to the genomic viral
RNA released in the media. Error bars indicate SD from at least
two independent experiments. (C) NS2 mutants protein stability.
Huh-7 cells were electroporated with viral RNA transcribed from
different JFH-1 derived mutants. At 72h post-electroporation, cells
were lysed, separated by SDS-PAGE and analyzed by Western
blotting with an anti-E2, anti-HA or anti-NS2. The actin content
was also analyzed to verify that equal amounts of cell lysates have
been loaded.
Found at: doi:10.1371/journal.ppat.1001278.s001 (3.05 MB TIF)
Figure S2 NS2 colocalization with the viral proteins. JFH-HA
electroporated cells grown on coverslips were fixed at 72h post-
electroporation and processed for double-label immunofluores-
cence for HA-NS2 (red) and HCV proteins core (C), NS5A or E1
(green). The nuclei were stained with DAPI (blue). Representative
confocal images of individual cells are shown in grey and the
colored merge images in the right column. Insets display zoomed
views of the indicated area. Bar, 10 mm.
Found at: doi:10.1371/journal.ppat.1001278.s002 (5.85 MB TIF)
Figure S3 Alternative subcellular localization of NS2. JFH-HA
electroporated cells grown on coverslips were fixed at 72h post-
electroporation and processed for double-label immunofluores-
cence for HA-NS2 (Red) and HCV core (C), ER-to-Golgi
intermediate compartment marker ERGIC-53, ER exit site
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marker sec31, or Golgi marker GM130 (Green). Nuclei were
stained with DAPI (Blue). Representative confocal images of
individual cells are shown with the merge images in the right
column. Cells showing NS2 alternative subcellular localization are
indicated by a star. Note the difference of ERGIC-53 and GM130
patterns in cells showing NS2 alternative subcellular localization.
Bar, 10 mm.
Found at: doi:10.1371/journal.ppat.1001278.s003 (8.33 MB TIF)
Figure S4 NS2 subcellular localization for JFH-HA-PP and
DE1E2 mutants. (A) Huh-7 cells electroporated with JFH-HA
RNA (WT) or JFH-HA-PP (PP) or JFH-DE1E2-HA (DE1E2)
genomes were grown on coverslips, fixed at 72h post-electropo-
ration and processed for triple-label immunofluorescence for HA-
NS2 (red), NS5A (blue) and LD (green). The nuclei were stained
with DAPI (grey). (B) E1-immunoreactive material (green) was
analyzed with the A4 Mab, together with HA-NS2 (red) for the
DE1E2 mutant and JFH-HA (WT). The nuclei were stained with
DAPI (blue). Representative confocal images of individual cells are
shown in grey with the colored merge images in the right column.
Bar, 10 mm.
Found at: doi:10.1371/journal.ppat.1001278.s004 (9.03 MB TIF)
Figure S5 The biphoton pictures for the positive and negative
control of FRET-FLIM analysis. U2OS cells were co-transfected
with plasmids expressing CFP-EYF and YFP-NS2 (negative
control, panel B) or CFP-E2TM and YFP-E1TM (positive control,
panel A). At 24h post-transfection, samples were subjected to
FLIM and color coded maps were obtained. The color bar
represent the progression from minimum (yellow) to maximum
(blue) fluorescence lifetime.
Found at: doi:10.1371/journal.ppat.1001278.s005 (2.02 MB TIF)
Table S1 Primers used for constructs.
Found at: doi:10.1371/journal.ppat.1001278.s006 (0.04 MB
DOC)
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